Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A J Windebank

Showing results (111-120 of 118) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 118 results.
The New England Journal of Medicine|November 21, 1991
Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significanceP J Dyck, P A Low, A J Windebank, et al.
Experimental Neurology|March 1, 1981
Acute hyperosmolar hyperglycemia causes axonal shrinkage and reduced nerve conduction velocityP J Dyck, E H Lambert, A J Windebank, et al.
Neurology|June 1, 1991
The Rochester Diabetic Neuropathy Study: design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic testsP J Dyck, K M Kratz, K A Lehman, et al.
Mayo Clinic Proceedings|March 1, 1990
Adrenal medullary transplantation into the brain for treatment of Parkinson's disease: clinical outcome and neurochemical studiesJ E Ahlskog, P J Kelly, J A van Heerden, et al.
The European Journal of Neuroscience|September 22, 2006
Dynamic role of kallikrein 6 in traumatic spinal cord injuryI A Scarisbrick, P Sabharwal, H Cruz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1999
Phase I trial of dolastatin-10 (NSC 376128) in patients with advanced solid tumorsH C Pitot, E A McElroy, J M Reid, et al.
Neurology|November 9, 2000
IV immunoglobulin does not reverse established weakness in MSJ H Noseworthy, P C O'Brien, B G Weinshenker, et al.
Journal of the Neurological Sciences|October 13, 2001
Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trialsS C Apfel, A K Asbury, V Bril, et al.
Pageof 12

Showing results (111-120 of 118) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 118 results.
The New England Journal of Medicine|November 21, 1991
Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significanceP J Dyck, P A Low, A J Windebank, et al.
Experimental Neurology|March 1, 1981
Acute hyperosmolar hyperglycemia causes axonal shrinkage and reduced nerve conduction velocityP J Dyck, E H Lambert, A J Windebank, et al.
Neurology|June 1, 1991
The Rochester Diabetic Neuropathy Study: design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic testsP J Dyck, K M Kratz, K A Lehman, et al.
Mayo Clinic Proceedings|March 1, 1990
Adrenal medullary transplantation into the brain for treatment of Parkinson's disease: clinical outcome and neurochemical studiesJ E Ahlskog, P J Kelly, J A van Heerden, et al.
The European Journal of Neuroscience|September 22, 2006
Dynamic role of kallikrein 6 in traumatic spinal cord injuryI A Scarisbrick, P Sabharwal, H Cruz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1999
Phase I trial of dolastatin-10 (NSC 376128) in patients with advanced solid tumorsH C Pitot, E A McElroy, J M Reid, et al.
Neurology|November 9, 2000
IV immunoglobulin does not reverse established weakness in MSJ H Noseworthy, P C O'Brien, B G Weinshenker, et al.
Journal of the Neurological Sciences|October 13, 2001
Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trialsS C Apfel, A K Asbury, V Bril, et al.
Pageof 12